Matteo Vitali, Nadim Naim Rodriguez, Pierluigi Pironti, Andreas Drossinos, Gaia Di Carlo, Anshuman Chawla, Fraschini Gianfranco
{"title":"ESWT和营养品补充(Tendisulfur Forte)与仅ESWT治疗外侧上髁炎、跟腱病和肩袖肌腱病的比较研究","authors":"Matteo Vitali, Nadim Naim Rodriguez, Pierluigi Pironti, Andreas Drossinos, Gaia Di Carlo, Anshuman Chawla, Fraschini Gianfranco","doi":"10.1080/21556660.2019.1605370","DOIUrl":null,"url":null,"abstract":"<p><p><b>Objective:</b> The purpose of this study was to determine the efficacy of Extracorporeal Shock Wave Therapy (ESWT) in combination with the dietary supplement Tendisulfur Forte in the treatment of shoulder tendinopathy, lateral epicondylitis, and Achilles tendinopathy. <b>Methods:</b> Patients were sub-divided for each pathology into two equal sized groups of 15: one treated with ESWT supplemented with Tendisulfur Forte, and the other treated with ESWT only. Shoulder functionality was measured through the UCLA shoulder score. Treatment of epicondylitis was assessed with the Mayo elbow score. Achilles tendinopathy was measured with the VISA-A score. Pain through the various groups of the study was measures with the Visual Analog Scale (VAS). <b>Results:</b> Patients in the Tendisulfur Forte group had overall better functional and VAS scale scores for shoulder tendinopathy, elbow epicondylitis, and Achilles tendinopathy. UCLA scores for shoulder tendinopathy showed significant results at 60 days in the Tendisulfur Forte group (<i>p</i> = 0.0002). Mayo scores in the treatment of lateral epicondylitis was significant at 60 days in the study group (<i>p</i> < 0.0001). Achilles tendinopathy was improved in the study group at 30 days (<i>p</i> < 0.0001). VAS scales were significant for each pathology at 60 days (<i>p</i> < 0.0001). In addition, NSAIDs consumption was greatly reduced and, in most cases, stopped in the Tendisulfur Forte Groups. <b>Conclusion:</b> Concerning the results obtained, this paper underlines the effectiveness of combined treatment of ESWT plus Tendisulfur Forte, in the absence of side-effects. Indeed, oral supplementation lead to a faster recovery and better outcomes with a significant reduction in NSAIDs consumption.</p>","PeriodicalId":15631,"journal":{"name":"Journal of Drug Assessment","volume":"8 1","pages":"77-86"},"PeriodicalIF":2.4000,"publicationDate":"2019-05-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/21556660.2019.1605370","citationCount":"14","resultStr":"{\"title\":\"ESWT and nutraceutical supplementation (Tendisulfur Forte) vs ESWT-only in the treatment of lateral epicondylitis, Achilles tendinopathy, and rotator cuff tendinopathy: a comparative study.\",\"authors\":\"Matteo Vitali, Nadim Naim Rodriguez, Pierluigi Pironti, Andreas Drossinos, Gaia Di Carlo, Anshuman Chawla, Fraschini Gianfranco\",\"doi\":\"10.1080/21556660.2019.1605370\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Objective:</b> The purpose of this study was to determine the efficacy of Extracorporeal Shock Wave Therapy (ESWT) in combination with the dietary supplement Tendisulfur Forte in the treatment of shoulder tendinopathy, lateral epicondylitis, and Achilles tendinopathy. <b>Methods:</b> Patients were sub-divided for each pathology into two equal sized groups of 15: one treated with ESWT supplemented with Tendisulfur Forte, and the other treated with ESWT only. Shoulder functionality was measured through the UCLA shoulder score. Treatment of epicondylitis was assessed with the Mayo elbow score. Achilles tendinopathy was measured with the VISA-A score. Pain through the various groups of the study was measures with the Visual Analog Scale (VAS). <b>Results:</b> Patients in the Tendisulfur Forte group had overall better functional and VAS scale scores for shoulder tendinopathy, elbow epicondylitis, and Achilles tendinopathy. UCLA scores for shoulder tendinopathy showed significant results at 60 days in the Tendisulfur Forte group (<i>p</i> = 0.0002). Mayo scores in the treatment of lateral epicondylitis was significant at 60 days in the study group (<i>p</i> < 0.0001). Achilles tendinopathy was improved in the study group at 30 days (<i>p</i> < 0.0001). VAS scales were significant for each pathology at 60 days (<i>p</i> < 0.0001). In addition, NSAIDs consumption was greatly reduced and, in most cases, stopped in the Tendisulfur Forte Groups. <b>Conclusion:</b> Concerning the results obtained, this paper underlines the effectiveness of combined treatment of ESWT plus Tendisulfur Forte, in the absence of side-effects. Indeed, oral supplementation lead to a faster recovery and better outcomes with a significant reduction in NSAIDs consumption.</p>\",\"PeriodicalId\":15631,\"journal\":{\"name\":\"Journal of Drug Assessment\",\"volume\":\"8 1\",\"pages\":\"77-86\"},\"PeriodicalIF\":2.4000,\"publicationDate\":\"2019-05-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/21556660.2019.1605370\",\"citationCount\":\"14\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Drug Assessment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/21556660.2019.1605370\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2019/1/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Drug Assessment","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/21556660.2019.1605370","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14
摘要
目的:本研究的目的是确定体外冲击波疗法(ESWT)联合膳食补充剂Tendisulfur Forte治疗肩腱病、外上髁炎和跟腱病的疗效。方法:根据每种病理将患者细分为两个大小相同的组,每组15人:一组用ESWT加Tendisulfur Forte治疗,另一组只用ESWT治疗。通过UCLA肩部评分测量肩部功能。用Mayo肘关节评分评估上髁炎的治疗。用VISA-A评分测量跟腱病变。通过视觉模拟量表(VAS)测量各组的疼痛。结果:Tendisulfur Forte组患者在肩关节肌腱病变、肘关节上髁炎和跟腱病变的功能评分和VAS评分上总体较好。在Tendisulfur Forte组,60天肩关节病变的UCLA评分显示出显著的结果(p = 0.0002)。研究组治疗外侧上髁炎60天Mayo评分显著(p p p)。结论:本文根据所得结果,强调了ESWT联合Tendisulfur Forte联合治疗的有效性,且无副作用。事实上,口服补充剂可以更快地恢复和更好地减少非甾体抗炎药的消耗。
ESWT and nutraceutical supplementation (Tendisulfur Forte) vs ESWT-only in the treatment of lateral epicondylitis, Achilles tendinopathy, and rotator cuff tendinopathy: a comparative study.
Objective: The purpose of this study was to determine the efficacy of Extracorporeal Shock Wave Therapy (ESWT) in combination with the dietary supplement Tendisulfur Forte in the treatment of shoulder tendinopathy, lateral epicondylitis, and Achilles tendinopathy. Methods: Patients were sub-divided for each pathology into two equal sized groups of 15: one treated with ESWT supplemented with Tendisulfur Forte, and the other treated with ESWT only. Shoulder functionality was measured through the UCLA shoulder score. Treatment of epicondylitis was assessed with the Mayo elbow score. Achilles tendinopathy was measured with the VISA-A score. Pain through the various groups of the study was measures with the Visual Analog Scale (VAS). Results: Patients in the Tendisulfur Forte group had overall better functional and VAS scale scores for shoulder tendinopathy, elbow epicondylitis, and Achilles tendinopathy. UCLA scores for shoulder tendinopathy showed significant results at 60 days in the Tendisulfur Forte group (p = 0.0002). Mayo scores in the treatment of lateral epicondylitis was significant at 60 days in the study group (p < 0.0001). Achilles tendinopathy was improved in the study group at 30 days (p < 0.0001). VAS scales were significant for each pathology at 60 days (p < 0.0001). In addition, NSAIDs consumption was greatly reduced and, in most cases, stopped in the Tendisulfur Forte Groups. Conclusion: Concerning the results obtained, this paper underlines the effectiveness of combined treatment of ESWT plus Tendisulfur Forte, in the absence of side-effects. Indeed, oral supplementation lead to a faster recovery and better outcomes with a significant reduction in NSAIDs consumption.